Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Alpha 4-2 beta 2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs.
Connolly J
,
Boulter J
,
Heinemann SF
.
???displayArticle.abstract???
1. Xenopus oocytes were injected with various muscle and neuronal nicotinic acetylcholine receptor (ACh receptor, cholinoceptor) subunit RNA combinations and their pharmacological properties studied using two-electrode voltage clamp. The functional expression of one of these combinations, rat alpha 4-2 beta 2, has not been previously described. The alpha 4-2 mRNA is a splicing variant transcribed from the alpha 4 gene. In the experiments reported here, the alpha 4-2 beta 2 subtype was functionally indistinguishable from the alpha 4-1 beta 2 subtype. 2. For each subtype, the relative potency of nicotine compared with acetylcholine was obtained by estimating the relative concentration of nicotine which would elicit the same current response as 0.1 microM Ach. The ratios of these concentrations (nicotine: ACh) for the mouse muscle ACh receptor-(alpha 1 beta 1 gamma delta) was 96.1:1. In contrast, the ratios for the rat neuronal subtypes were: alpha 2 beta 2, 1.01:1; alpha 3 beta 2, 2.01:1; alpha 4 beta 2, 0.76:1 and alpha 4-2 beta 2, 0.76:1. The much greater relative nicotine sensitivity of the neuronal subtypes as compared with muscle receptors illustrates their potential to mediate the psychoactive and addictive effects of nicotine. However, it does not appear that the differences in relative nicotinic sensitivity among the neuronal receptors themselves can be used as a simple discriminative tool in neuronal tissue. 3. The slopes of the log dose-log response curves at low ACh concentrations were all greater than 1 but less than 2, suggesting that at least two agonist binding sites mediate the functional response of each hetero-oligomer. 4. The response of all the neuronal subtypes to ACh could be inhibited by the psychoactive drugs mecamylamine, amitriptyline, phencyclidine, trifluoperazine and promethazine. With the exception of the very potent antagonist, mecamylamine, the degree of block of the peak current to ACh produced by 10 microM concentrations of these drugs was remarkably similar (around 50%). 5. The degree of inhibition produced when the antipsychotic drug, trifluoperazine, was co-applied with ACh increased as the duration of application increased. Such an effect was not observed with promethazine, a related phenothiazine derivative which does not have antipsychotic actions.
Albuquerque,
Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor.
1980, Pubmed
Albuquerque,
Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor.
1980,
Pubmed
Amador,
MK-801 inhibition of nicotinic acetylcholine receptor channels.
1991,
Pubmed
Anand,
Nucleotide sequence of the human nicotinic acetylcholine receptor beta 2 subunit gene.
1990,
Pubmed
Ascher,
Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells.
1979,
Pubmed
Ballivet,
Electrophysiology of a chick neuronal nicotinic acetylcholine receptor expressed in Xenopus oocytes after cDNA injection.
1988,
Pubmed
,
Xenbase
Baron,
Cigarette smoking and Parkinson's disease.
1986,
Pubmed
Benowitz,
Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.
1988,
Pubmed
Bertrand,
Activation and blocking of neuronal nicotinic acetylcholine receptor reconstituted in Xenopus oocytes.
1990,
Pubmed
,
Xenbase
Boulter,
Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor.
1985,
Pubmed
Boulter,
Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster.
1990,
Pubmed
Boulter,
Isolation and sequence of cDNA clones coding for the precursor to the gamma subunit of mouse muscle nicotinic acetylcholine receptor.
1986,
Pubmed
Boulter,
Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit.
,
Pubmed
Boulter,
Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family.
1987,
Pubmed
,
Xenbase
Brazell,
Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen.
1990,
Pubmed
Buller,
Functional acetylcholine receptors expressed in Xenopus oocytes after injection of Torpedo beta, gamma, and delta subunit RNAs are a consequence of endogenous oocyte gene expression.
1990,
Pubmed
,
Xenbase
Changeux,
Effects of chlorpromazine and phencyclidine on mouse C2 acetylcholine receptor kinetics.
1986,
Pubmed
Clapham,
Trifluoperazine reduces inward ionic currents and secretion by separate mechanisms in bovine chromaffin cells.
1984,
Pubmed
Clarke,
Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin.
1985,
Pubmed
Connelly,
Lack of stereoselectivity in ability of nicotine to release dopamine from rat synaptosomal preparations.
1983,
Pubmed
Connolly,
Structure-function relationships in nicotinic acetylcholine receptors.
1989,
Pubmed
Conti-Tronconi,
Brain and muscle nicotinic acetylcholine receptors are different but homologous proteins.
1985,
Pubmed
Cooper,
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.
1991,
Pubmed
Couturier,
A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX.
1990,
Pubmed
,
Xenbase
Couturier,
Alpha 5, alpha 3, and non-alpha 3. Three clustered avian genes encoding neuronal nicotinic acetylcholine receptor-related subunits.
1990,
Pubmed
,
Xenbase
Creese,
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
1976,
Pubmed
CURTIS,
The excitation of Renshaw cells by pharmacological agents applied electrophoretically.
1958,
Pubmed
Deneris,
Primary structure and expression of beta 2: a novel subunit of neuronal nicotinic acetylcholine receptors.
1988,
Pubmed
,
Xenbase
Deneris,
Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors.
1991,
Pubmed
,
Xenbase
Dilger,
Direct measurement of the concentration- and time-dependent open probability of the nicotinic acetylcholine receptor channel.
1990,
Pubmed
Fornasari,
Molecular cloning of human neuronal nicotinic receptor alpha 3-subunit.
1990,
Pubmed
Franke,
Steep concentration dependence and fast desensitization of nicotinic channel currents elicited by acetylcholine pulses, studied in adult vertebrate muscle.
1991,
Pubmed
Giraudat,
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains.
1987,
Pubmed
Giraudat,
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine.
1986,
Pubmed
Goldman,
Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system.
1987,
Pubmed
Halliwell,
The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.
1989,
Pubmed
Hartman,
Coexpression of two distinct muscle acetylcholine receptor alpha-subunits during development.
1990,
Pubmed
,
Xenbase
Heidmann,
Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata.
1983,
Pubmed
Higashi,
5-Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia.
1982,
Pubmed
Hill,
The mode of action of nicotine and curari, determined by the form of the contraction curve and the method of temperature coefficients.
1909,
Pubmed
Imoto,
Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance.
1988,
Pubmed
,
Xenbase
Kavanaugh,
Interaction of MK-801 with the nicotinic acetylcholine receptor-associated ion channel from electroplax.
1989,
Pubmed
Kurosaki,
Functional properties of nicotinic acetylcholine receptor subunits expressed in various combinations.
1987,
Pubmed
,
Xenbase
Luetje,
Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.
1991,
Pubmed
,
Xenbase
Lukas,
Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
1989,
Pubmed
Luther,
A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671.
1989,
Pubmed
MacDonald,
Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine.
1987,
Pubmed
Melton,
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.
1984,
Pubmed
Moss,
Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders.
1989,
Pubmed
O'Dell,
Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate- and aspartate-induced currents in horizontal cells dissociated from the catfish retina.
1988,
Pubmed
Papke,
Mechanisms of noncompetitive inhibition of acetylcholine-induced single-channel currents.
1989,
Pubmed
Papke,
The role of the beta 4-subunit in determining the kinetic properties of rat neuronal nicotinic acetylcholine alpha 3-receptors.
1991,
Pubmed
,
Xenbase
Papke,
Single-channel currents of rat neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
1989,
Pubmed
,
Xenbase
Peters,
Antagonism of 5-HT3 receptor mediated currents in murine N1E-115 neuroblastoma cells by (+)-tubocurarine.
1990,
Pubmed
Rapier,
Nicotinic modulation of [3H]dopamine release from striatal synaptosomes: pharmacological characterisation.
1990,
Pubmed
Revah,
The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel.
1990,
Pubmed
Richardson,
Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.
,
Pubmed
Schoepfer,
cDNA clones coding for the structural subunit of a chicken brain nicotinic acetylcholine receptor.
1988,
Pubmed
Schulz,
Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum.
1989,
Pubmed
Seeman,
Antipsychotic drug doses and neuroleptic/dopamine receptors.
1976,
Pubmed
Sernagor,
Open channel block of NMDA receptor responses evoked by tricyclic antidepressants.
1989,
Pubmed
Seyler,
Pituitary hormone response to cigarette smoking.
1986,
Pubmed
Swanson,
Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system.
1987,
Pubmed
Takano,
Presynaptic modulation of the release of dopamine from striatal synaptosomes: differences in the effects of high K+ stimulation, methamphetamine and nicotinic drugs.
1983,
Pubmed
Vanner,
Effects of 5-HT3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones.
1990,
Pubmed
Vendsborg,
Lithium treatment and weight gain.
1976,
Pubmed
Wack,
Smoking and its effects on body weight and the systems of caloric regulation.
1982,
Pubmed
Wada,
Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat.
1989,
Pubmed
,
Xenbase
Wada,
Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptor.
1988,
Pubmed
,
Xenbase
Wesnes,
Smoking, nicotine and human performance.
1983,
Pubmed
Whitehouse,
Reductions in acetylcholine and nicotine binding in several degenerative diseases.
1988,
Pubmed
Whiting,
Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies.
1987,
Pubmed
Whiting,
Neuronal nicotinic acetylcholine receptor beta-subunit is coded for by the cDNA clone alpha 4.
1987,
Pubmed
Yakel,
5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line.
1988,
Pubmed
Yoshii,
Equilibrium properties of mouse-Torpedo acetylcholine receptor hybrids expressed in Xenopus oocytes.
1987,
Pubmed
,
Xenbase